ChrysCapital
ChrysCapital is an India-focused growth and control investor founded in 1999, with a concentrated sector playbook across technology, financial services, healthcare, consumer and manufacturing. It has built a long operating history around value creation and exits rather than a broad multi-strategy platform.
At a glance
- Founded
- 1999
- Footprint
- Mumbai
- Stage
- Growth + buyout (up to $200M/deal)
Research profile
Read the manager in sequence.
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
ChrysCapital uses a growth + buyout (up to $200m/deal) approach across Fin services, health, pharma, consumer.
Current evidence
ChrysCapital announced the final close of Fund X at $2.2 billion in 2025, describing it as the largest India-focused private-equity fund to date; its current portfolio page names companies including WOW Skin Science, Lenskart, MoEngage, Mphasis, KPIT, Infogain, Hexaware, Safex Chemicals, GMM Pfaudler, FirstCry, Dream Sports and Awfis.
Strategy
Growth + buyout (up to $200M/deal)
Sector focus
Fin services, health, pharma, consumer
Current signal
ChrysCapital announced the final close of Fund X at $2.2 billion in 2025, describing it as the largest India-focused private-equity fund to date; its current portfolio page names companies including WOW Skin Science, Lenskart, MoEngage, Mphasis, KPIT, Infogain, Hexaware, Safex Chemicals, GMM Pfaudler, FirstCry, Dream Sports and Awfis.
Next step
Need this manager reviewed against your mandate?
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.